Diane D. Liu
The University of Texas MD Anderson Cancer Center(US)Cornell University(US)Weill Cornell Medicine(US)
Publications by Year
Research Areas
FOXO transcription factor regulation, Immunotherapy and Immune Responses, Monoclonal and Polyclonal Antibodies Research, Cancer Immunotherapy and Biomarkers, Palliative Care and End-of-Life Issues
Most-Cited Works
- → KRASMutation Is an Important Predictor of Resistance to Therapy with Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Non–Small-Cell Lung Cancer(2007)600 cited
- → Phase I/II Trial Evaluating the Anti-Vascular Endothelial Growth Factor Monoclonal Antibody Bevacizumab in Combination With the HER-1/Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Erlotinib for Patients With Recurrent Non–Small-Cell Lung Cancer(2005)536 cited
- Lack of PTEN expression in non-small cell lung cancer could be related to promoter methylation.(2002)
- → Epidermal Growth Factor Receptor Copy Number Alterations Correlate With Poor Clinical Outcome in Patients With Head and Neck Squamous Cancer(2007)399 cited
- → Overexpression of podoplanin in oral cancer and its association with poor clinical outcome(2006)304 cited
- → ETS2 Mediated Tumor Suppressive Function and MET Oncogene Inhibition in Human Non–Small Cell Lung Cancer(2013)191 cited